Progression of CD8-positive Sézary syndrome from mycosis fungoides following dupilumab treatment

Eur J Dermatol. 2024 Jun 1;34(3):294-296. doi: 10.1684/ejd.2024.4729.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Aged
  • Antibodies, Monoclonal, Humanized* / adverse effects
  • Antibodies, Monoclonal, Humanized* / therapeutic use
  • CD8-Positive T-Lymphocytes
  • Disease Progression
  • Female
  • Humans
  • Male
  • Middle Aged
  • Mycosis Fungoides* / drug therapy
  • Mycosis Fungoides* / pathology
  • Sezary Syndrome* / drug therapy
  • Skin Neoplasms* / drug therapy
  • Skin Neoplasms* / pathology

Substances

  • Antibodies, Monoclonal, Humanized
  • dupilumab